PCI Pharma Services has officially opened its newly expanded Clinical Center of Excellence in Rockford, IL. The US biopharmaceutical outsourcing services provider added 30,000 sqft of additional space with increased flexibility and scalability for primary and secondary packaging, labelling, and 2-8°C cold chain storage.
Construction began in November 2018 and was completed this month, delivering the 30,000 sqft of additional space. The expansion also includes a new customer reception area as well as increased office space to support PCI staff growth.
Rockford City Council Director of Community and Economic Development, Karl Franzen, said: “Established and growing companies such as PCI play a critical role in our economic development, including creating employment opportunities for local people. We can all be proud that PCI’s presence here reflects the significance of the manufacturing sector in the Midwest.”
The premiere featured key community and PCI leadership, who welcomed the opening as a major advancement for customers and ultimately patients in clinical trials.
PCI’s Chief Operating Officer Brad Payne added: “The Rockford Clinical facility expansion delivers significant new capacity across our core offerings of primary and secondary packaging as well as cold chain storage and distribution. This investment is one of many PCI is making across our global clinical supply chain in strategic locations in the US, UK, Europe, and Australia to ensure we can meet our clients’ global needs by packaging and delivering life-saving therapeutic products to patients worldwide.”
Commenting on the growth and future of PCI’s Clinical business, PCI’s Brian Keesee, VP and General Manager of Global Operations and Supply for Clinical Services explained that the new suites in Rockford provide faster turnaround times and increased flexibility.
The Rockford site is the largest of PCI’s eight locations across the US, EU and the Asia Pacific regions – supporting clinical trials in more than 100 countries around the world.
